ROME, N.Y. — Rome Health has expanded its cardiac diagnostic services with two new advanced imaging exams — CT coronary artery calcium scoring and nuclear medicine cardiac amyloidosis imaging — that can detect and diagnose heart disease at earlier stages, offering the community improved access to cardiovascular care, the hospital announced.
CT coronary artery calcium scoring is a non-invasive imaging test that measures the amount of calcium buildup in the coronary arteries, providing insights into a patient’s risk for coronary artery disease and guiding preventative care and treatment strategies. The exam is currently offered on a self-pay basis for $125.
Nuclear medicine cardiac amyloidosis imaging is a specialized diagnostic test that detects amyloid protein deposits in the heart. Cardiac amyloidosis can lead to heart failure if left undiagnosed. With the advanced imaging capability, Rome Health offers early detection and improved management options for patients at risk. The exam is reimbursable by insurance.
(Sponsored)
How CH Insurance’s BOOST Program Optimizes Group Benefits for Small Businesses
For small business owners, navigating the complexities of group benefits can be overwhelming. Between compliance regulations, cost considerations, and employee expectations, offering a competitive benefits package often feels like a
How Are You Creating Certainty in an Uncertain World?
In a world of constant change, having a local partner in your corner can make all the difference. When Central NY businesses are asked “Who’s in your corner?” one name
“At Rome Health, we remain committed to expanding access to high-quality, state-of-the-art healthcare close to home,” Rome Health Medical Director of Medical Imaging John Restivo said in the announcement. “The addition of these two imaging exams reflects our dedication to enhancing cardiac care and ensuring our patients receive the best possible diagnostic and treatment options.”
The new exams are available at Rome Health Monday through Friday.
